PAF-acetylhydrolase expressed during megakaryocyte differentiation inactivates PAF-like lipids

Blood

Volumn 113, Issue 26, 2009, Pages 6699-6706

  Foulks, Jason M ^a   Marathe, Gopal K ^b   Michetti, Noemi ^a   Stafforini, Diana M ^a,c   Zimmerman, Guy A ^a   McIntyre, Thomas M ^b   Weyrich, Andrew S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; CD34 ANTIGEN; FIBRINOGEN RECEPTOR; MESSENGER RNA; PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; IL3 PROTEIN, HUMAN; INTERLEUKIN 3; STEM CELL FACTOR; THROMBOPOIETIN;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL MOTILITY; CELL SPREADING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CALCIUM SIGNALING; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; FETUS BLOOD; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM; PHYSIOLOGY; THROMBOCYTOPOIESIS;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; CALCIUM SIGNALING; CELL ADHESION; CELLS, CULTURED; ENZYME INDUCTION; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; MEGAKARYOCYTES; PHOSPHOLIPIDS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; STEM CELL FACTOR; THROMBOPOIESIS; THROMBOPOIETIN;

EID: 69249223475     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-11-186312     Document Type: Article

References (55)

1. Hanahan DJ. Platelet activating factor: a biologically active phosphoglyceride. Annu Rev Biochem. 1986;55:483-509. (Pubitemid 16070778)
2. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem. 2000; 69:419-445.
3. Marathe GK, Prescott SM, Zimmerman GA, McIntyre TM. Oxidized LDL contains inflammatory PAF-like phospholipids. Trends Cardiovasc Med. 2001;11:139-142.
4. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med. 2002;30:S294-S301.
5. McIntyre TM, Zimmerman GA, Prescott SM. Biologically active oxidized phospholipids. J Biol Chem. 1999;274:25189-25192.
6. Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM. Platelet-activating factor acetylhydrolases. J Biol Chem. 1997;272:17895-17898.
7. Zimmerman GA, Elstad MR, Lorant DE, et al. Platelet-activating factor (PAF): signalling and adhesion in cell-cell interactions. Adv Exp Med Biol. 1996;416:297-304.
8. Denizot Y, Rougier F, Dupuis F, et al. PAF and hematopoiesis: VIII, biosynthesis and metabolism of PAF by human bone marrow stromal cells. Exp Hematol. 1996;24:1327-1332. (Pubitemid 26348930)
9. Desplat V, Besse A, Faucher JL, Praloran V, Denizot Y. Expression of platelet-activating factor receptor transcript-1 but not transcript-2 by human bone marrow cells. Stem Cells. 1999;17: 121-124. (Pubitemid 29149402)
10. Kato T, Kudo I, Hayashi H, Onozaki K, Inoue K. Augmentation of DNA synthesis in guinea pig bone marrow cells by platelet-activating factor (PAF). Biochem Biophys Res Commun. 1988; 157:563-568. (Pubitemid 19021216)
11. Rougier F, Dupuis F, Cornu E, Dulery C, Praloran V, Denizot Y. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures. J Lipid Mediat Cell Signal. 1997;16:147-153. (Pubitemid 27285836)
12. Denizot Y, Godard A, Raher S, Trimoreau F, Praloran V. Lipid mediators modulate the synthesis of interleukin 8 by human bone marrow stromal cells. Cytokine. 1999;11:606-610. (Pubitemid 29368979)
13. Denizot Y, Raher S, Trimoreau F, Praloran V, Godard A. Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells. Cytokine. 2000;12: 499-502. (Pubitemid 30449851)
14. Denizot Y, Trimoreau F, Praloran V. Effects of lipid mediators on the synthesis of leukaemia inhibitory factor and interleukin 6 by human bone marrow stromal cells. Cytokine. 1998;10:781-785. (Pubitemid 28495229)
15. Fixe P, Rougier F, Ostyn E, et al. Spontaneous and inducible production of macrophage colony-stimulating factor by human bone marrow stromal cells. Eur Cytokine Netw. 1997;8:91-95. (Pubitemid 27189861)
16. Bellone G, Astarita P, Artusio E, et al. Bone marrow stroma-derived prolactin is involved in basal and platelet-activating factor-stimulated in vitro erythropoiesis. Blood. 1997;90:21-27. (Pubitemid 27276542)
17. Dupuis F, Desplat V, Praloran V, Denizot Y. Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. J Lipid Mediat Cell Signal. 1997;16:117-125. (Pubitemid 27285833)
18. den Dekker E, Gorter G, van der Vuurst H, Heemskerk JW, Akkerman JW. Biogenesis of G-protein mediated calcium signaling in human megakaryocytes. Thromb Haemost. 2001;86: 1106-1113. (Pubitemid 32975840)
19. Arai H, Koizumi H, Aoki J, Inoue K. Platelet-activating factor acetylhydrolase (PAF-AH). J Biochem (Tokyo). 2002;131:635-640.
20. Stafforini DM, Satoh K, Atkinson DL, et al. Platelet-activating factor acetylhydrolase deficiency: a missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest. 1996;97:2784-2791. (Pubitemid 26197091)
21. Asano K, Okamoto S, Fukunaga K, et al. Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma. Biochem Biophys Res Commun. 1999;261:511-514. (Pubitemid 29392507)
22. Denizot Y, Rougier F, Dupuis F, et al. Presence and metabolism of lyso platelet-activating factor in human bone marrow. J Lipid Mediat Cell Signal. 1997;16:53-62. (Pubitemid 27191396)
23. Dupuis F, Rougier F, Trimoreau F, et al. Production and metabolism of platelet-activating factor by human bone marrow cells. Res Immunol. 1997;148:119-126. (Pubitemid 27287154)
24. Nakajima K, Murakami M, Yanoshita R, et al. Activated mast cells release extracellular type platelet-activating factor acetylhydrolase that contributes to autocrine inactivation of platelet-activating factor. J Biol Chem. 1997;272:19708-19713. (Pubitemid 27340059)
25. Denis MM, Tolley ND, Bunting M, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell. 2005; 122:379-391. (Pubitemid 41127140)
26. Schwertz H, Tolley ND, Foulks JM, et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets. J Exp Med. 2006;203:2433-2440. (Pubitemid 44664613)
27. Weyrich AS, Denis MM, Schwertz H, et al. mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood. 2007;109:1975-1983. (Pubitemid 46348195)
28. Galt SW, Lindemann S, Allen L, et al. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res. 2002;90: 1093-1099. (Pubitemid 34627908)
29. Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol. 2001;154:485-490. (Pubitemid 34286155)
30. Weyrich AS, Elstad MR, McEver RP, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 1996;97:1525-1534.
31. Prescott SM, Zimmerman GA, McIntyre TM. Human endothelial cells in culture produce plateletactivating factor (1-alkyl-2-acetyl-sn-glycero-3- phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A. 1984;81:3534-3538.
32. Stafforini DM, McIntyre TM, Prescott SM. Platelet-activating factor acetylhydrolase from human plasma. Methods Enzymol. 1990;187: 344-357. (Pubitemid 20309300)
33. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408. (Pubitemid 34164012)
35. Dupré DJ, Thompson C, Chen Z, et al. Inverse agonist-induced signaling and down-regulation of the platelet-activating factor receptor. Cell Signal. 2007;19:2068-2079. (Pubitemid 47353809)
36. Marathe GK, Silva AR, de Castro Faria Neto HC, et al. Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. J Lipid Res. 2001;42:1430-1437.
37. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
38. Angelloz-Nicoud P, Harel L, Binoux M. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases. Growth Regul. 1996;6: 130-136.
39. Diatchuk V, Lotan O, Koshkin V, Wikstroem P, Pick E. Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem. 1997;272: 13292-13301. (Pubitemid 27216760)
40. Dentan C, Tselepis AD, Chapman MJ, Ninio E. Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase. Biochim Biophys Acta. 1996;1299:353-357. (Pubitemid 26064757)
41. Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem. 1985;260:11107-11114. (Pubitemid 16253272)
42. Stafforini DM, Elstad MR, McIntyre TM, Zimmerman GA, Prescott SM. Human macrophages secret platelet-activating factor acetylhydrolase. J Biol Chem. 1990;265:9682-9687. (Pubitemid 20194309)
43. Elstad MR, Stafforini DM, McIntyre TM, Prescott SM, Zimmerman GA. Platelet-activating factor acetylhydrolase increases during macrophage differentiation: a novel mechanism that regulates accumulation of platelet-activating factor. J Biol Chem. 1989;264:8467-8470.
44. Mitsios JV, Vini MP, Stengel D, Ninio E, Tselepis AD. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles. Arterioscler Thromb Vasc Biol. 2006;26:1907-1913. (Pubitemid 44305349)
45. Touqui L, Hatmi M, Vargaftig BB. Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3- phosphocholine) when the degrading enzyme acetyl hydrolase is blocked. Biochem J. 1985; 229:811-816. (Pubitemid 15243730)
46. Ostrovsky L, King AJ, Bond S, et al. A juxtacrine mechanism for neutrophil adhesion on platelets involves platelet-activating factor and a selectin-dependent activation process. Blood. 1998;91: 3028-3036. (Pubitemid 28227556)
47. Chen J, Yang L, Foulks JM, Weyrich AS, Marathe GK, McIntyre TM. Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis. J Lipid Res. 2007;48:2365-2376. (Pubitemid 350058748)
48. Eto K, Murphy R, Kerrigan SW, et al. Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci U S A. 2002;99:12819-12824.
49. Shiraga M, Ritchie A, Aidoudi S, et al. Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin alphaIIbbeta3 signaling. J Cell Biol. 1999;147:1419-1430. (Pubitemid 30027398)
50. Gaur M, Kamata T, Wang S, Moran B, Shattil SJ, Leavitt AD. Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost. 2006;4:436-442.
51. Gaudreault E, Stankova J, Rola-Pleszczynski M. Involvement of leukotriene B4 receptor 1 signaling in platelet-activating factor-mediated neutrophil degranulation and chemotaxis. Prostaglandins Other Lipid Mediat. 2005;75:25-34. (Pubitemid 40248376)
52. Shen Y, Sultana C, Arditi M, Kim KS, Kalra VK. Endotoxin-induced migration of monocytes and PECAM-1 phosphorylation are abrogated by PAF receptor antagonists. Am J Physiol. 1998;275: E479-E486. (Pubitemid 28436068)
53. Tokuoka SM, Ishii S, Kawamura N, et al. Involvement of platelet-activating factor and LIS1 in neuronal migration. Eur J Neurosci. 2003;18:563-570. (Pubitemid 37041105)
54. Tong N, Sanchez JF, Maggirwar SB, et al. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur J Neurosci. 2001;13:1913-1922. (Pubitemid 32537217)
55. MacRitchie AN, Gardner AA, Prescott SM, Stafforini DM. Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation. FASEB J. 2007;21:1164-1176.